BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-242@pharmaconomics
DTSTAMP:20260707T034602Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:RCKT Phase 2 — RP-A501 (estimated date)
DESCRIPTION:Phase 2 trial results for RP-A501 in Danon disease are due ~ Jun 30\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1281895/000114036126006981/ef20066645_ex99-1.htm\n\nTrack it: https://www.pharmaconomics.com/e/242
URL:https://www.pharmaconomics.com/e/242
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:RCKT catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR